Hypermobility in patients with chronic fatigue syndrome: Preliminary observations

Journal of Musculoskeletal Pain

Volumn 12, Issue 1, 2004, Pages 9-17

  Nijs, Jo ^a,b   De Meirleir, Kenny ^a   Truyen, Steven ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b Hogeschool Antwerpen   (Belgium)

Author keywords

Chronic fatigue syndrome; Hypermobility; Pain; Prevalence

Indexed keywords

ADULT; ARTHRALGIA; ARTICLE; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; DISEASE DURATION; FATIGUE; FEMALE; HUMAN; HYPERMOBILITY; JOINT MOBILITY; MALE; MYALGIA; PAIN; QUESTIONNAIRE; SYNDROME DELINEATION; VISUAL ANALOG SCALE;

EID: 3042594458     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/J094v12n01_03     Document Type: Article

References (52)

1. Bombardier CH, Buchwald D: Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health care use. Med Care 34: 924-30, 1996.
2. Goldenberg DL: Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 3: 247-258, 1991.
3. Klimas N, Salvato F, Morgan R, Fletcher MA: Immunological abnormalities in chronic fatigue syndrome. J Clin Microbiol 28: 1403-1410, 1990.
4. Hudson N, Starr MR, Esdaile JM, Fitzcharles M-A: Diagnostic associations with hypermobility in rheumatology patients. Br J Rheumatol 34: 1157-1161, 1995.
5. Karaaslan Y, Haznedaroglu S, Öztürk M: Joint hypermobility and primary fibromyalgia: A clinical enigma. J Rheumatol 27: 1774-6, 2000.
6. Norton PA, Baker JE, Sharp HC, Warenski JC: Genitourinary prolapse and joint hypermobility in women. Obstet Gynecol 85: 225-228, 1995.
7. Seow CC, Chow PK, Khong KS: A study of joint mobility in a normal population. Ann Acad Med Singapore 28: 231-6, 1999.
8. Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT: Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 135: 494-9, 1999.
9. Gannon LM, Bird HA: The quantification of joint laxity in dancers and gymnasts. J Sports Sci 17: 743-50, 1999.
10. Hall MG, Ferrell WR, Sturrock RD, Hamblen DL, Baxendale RH: The effect of the hypermobility syndrome on knee joint proprioception. Br J Rheumatol 34:121-125, 1995.
11. Mallik AK, Ferrell WR, McDonald AG, Sturrock RD: Impaired proprioceptive acuity at the proximal interphalangeal joint in patients with the hypermobility syndrome. Br J Rheumatol 33: 631-637, 1994.
12. Fitzcharles M-A: Is hypermobility a factor in fibromyalgia? J Rheumatol 27: 1587-1589, 2000.
13. Lai S, Goldman JA, Child AH, Engel A, Lamm SH: Fibromyalgia, hypermobility, and breast implants. J Rheumatol 27: 2237-41, 2000.
14. Gedalia A, Press J, Klein M, Buskila D: Joint Hypermobility and fibromyalgia in schoolchildren. Ann Rheum Dis 52: 494-496, 1993.
15. Barrow DF, Cohen BA, Geraghty MT, Violand R, Rowe PC: Joint hypermobility is more common in children with chronic fatigue syndrome than in healthy controls. J Pediatr 141: 421-5, 2002.
16. Beighton PH, Solomon L, Soskolne CL: Articular mobility in an African population. Ann Rheum Dis 32: 413-7, 1973.
17. Fukuda K, Strauss SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, and the International Chronic Fatigue Syndrome Study Group: The Chronic Fatigue Syndrome, a comprehensive approach to its definition and study. Ann Intern Med 121: 953-959, 1994.
18. Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, Akiya K: Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: A possible marker for hypersomnia and cognitive disorders. Rheumatology 40: 806-810, 2001.
19. Tan EM, Sugura K, Gupta S: The case definition of chronic fatigue syndrome. J Clin Immunol 22: 8-12, 2002.
20. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33: 160-172, 1990.
21. Hudson N, Fitzcharles MA, Cohen M, Starr MR, Esdaile JM: The association of soft-tissue rheumatism and hypermobility. Br J Rheumatol 37: 382-6, 1998.
22. Grahame R: Joint hypermobility and genetic collagen disorders: Are they related? Arch Dis Child 80: 188-191, 1999.
23. Carter C, Wilkinson J: Persistent joint laxity and congenital dislocation of the hip. J Bone Joint Surg 46: 40-45, 1964.
24. De Meirleir K, Peterson DL, De Becker P, Englebienne P: From laboratory to patient care; Chronic fatigue Syndrome: A biological approach. Edited by P Englebienne, K De Meirleir, CRC Press. Boca Raton, 2002, pp. 265-284.
25. Nijs J, Vaes P, McGregor N, Van Hoof E, De Meirleir K: Activity limitations and participation restrictions in patients with chronic fatigue syndrome-Construction of a disease specific questionnaire. J Chronic Fatigue Syndr 10: 3-23, 2002.
26. Nijs J, Vaes P, McGregor N, Van Hoof E, De Meirleir K: Psychometric properties of the Dutch Chronic Fatigue Syndrome Activities and Participation Questionnaire (CFS-APQ). Phys Ther 83: 444-454, 2003.
27. Anderson JS, Ferrans CE: The quality of life of persons with chronic fatigue syndrome. J Nerv Ment Dis 185: 359-367, 1997.
28. Harms-Ringdahl K, Carlsson AM, Ekholm J, Raustorp A, Svensson T, Toresson HG: Pain assessment with different intensity scales in response to loading joint structures. Pain 27: 401-412, 1986.
29. Jensen MD, Koroly P, Braver S: The measurement of clinical pain intensity: A comparison of six methods. Pain 27: 117-126, 1986.
30. Bulbena A, Duró JC, Porta M, Faus S, Vallescar R, Martín-Santos R: Clinical assessment of hypermobility of joints: Assembling criteria. J Rheumatol 19: 115-122, 1992.
31. Portney LG, Watkins MP: Foundations of clinical research-applications to practice (second ed). Prentice Hall Health. New Jersey, 2000, pp. 475-8.
32. Fritz JM, Wainner RS: Examining diagnostic tests: An evidence-based perspective. Phys Ther 81: 1546-1564, 2001.
33. Acususo-Diaz M, Collantes-Estevez E: Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res 11: 39-42, 1998.
34. Jessee EF, Owen DS Jr, Sagar KB: The benign hypermobility joint syndrome. Arthritis Rheum 23: 1053-6, 1980.
35. Donnay A, Ziem G: Prevalence and overlap of chronic fatigue syndrome and fibromyalgia syndrome among 100 new patients with multiple chemical sensitivity syndrome. J Chronic Fatigue Syndr 5: 71-80, 1999.
36. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19-28, 1995.
37. Goldenberg DL, Silmms RW, Geiger A, Komaroff AL: High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Arthritis Rheum 33:381-387, 1990.
38. De Meirleir K, Bisbal C, Campine I, De Becker P, Salehzada T, Demettre E, Lebleu B: A 37-kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 108: 99-105, 2000.
39. Snell CR, Vanness JM, Strayer DR, Stevens SR: Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome. In Vivo 16: 107-9, 2002.
40. Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Müller WEG, Schröder HC, Carter WA, Strayer DR: Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18 (Suppl): 96-104, 1994.
41. Engelbienne P, De Meirleir K: Chronic fatigue Syndrome: A biological approach. CRC Press, Boca Raton, 2002.
42. Demettre E, Bastide L, D'Haese A, De Smet K, De Meirleir K, Tiev KP, Englebienne P, Lebleu B: Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J Biol Chem 277: 35746-35751, 2002.
43. Yuan H, Kononov S, Cavalcante FSA, Lutchen KR, Ingenito EP, Suki B: Effects of collagenase and elastase on the mechanical properties of lung tissue strips. J Appl Physiol 89: 3-14, 2000.
44. Gigante A, Chillemi C, Greco F: Changes of elastic fibers in musculoskeletal tissues of Marfan syndrome: A possible mechanism of joint laxity and skeletal overgrowth. J Pediatr Orthop 19: 283-8, 1999.
45. Nasralla M, Haier J, Nicolson GL: Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome. Eur J Clin Microbiol Infect Dis 18: 859-865, 1999.
46. Vojdani A, Choppa PC, Tagle C, Andrin R, Samini B, Lapp CW: Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with Chronic Fatigue Syndrome. FEMS Immunol Med Microbiol 22: 355-365, 1998.
47. Nijs J, Nicolson GL, De Becker P, Coomans D, De Meirleir K: High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients. FEMS Immunol Med Microbiol 34: 209-214, 2002.
48. Baseman J, Tully J: Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 3: 21-32, 1997.
49. Baum SC: Mycoplasma pneumoniae and atypical pneumonia, Principles and practice of infectious diseases. Edited by GL Mandell, JE Bennet, R Dolin. Churchill Livingstone, New York, 1995, pp. 1713-1718.
50. Peterszegi G, Texier S, Robert L: Cell death by overload of the elastin-laminin receptor on human activated lymphocytes: Protection by lactose and melibiose. Eur J Clin Invest 29: 166-172, 1999.
51. Dabbagh K, Laurent GJ, Shock A, Leoni P, Papakrivopoulou J, Chambers RC: Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J Cell Physiol 186: 73-81, 2001.
52. De Meirleir K, De Becker P, Nijs J, Peterson D, Nicolson G, Patarca-Montero R, Englebienne P: CFS etiology, the immune system, and infection: Chronic fatigue Syndrome: A biological approach. Edited by P Englebienne, K De Meirleir. CRC Press, Boca Raton, 2002, pp. 201-228.